Thursday, 18 Oct 2018

You are here

Back Pain in Psoriatic Arthritis

A single center study of psoriatic arthritis patients has shown that rheumatologist-judged inflammatory back pain (IBP) and criteria defining IBP may not perform well when ascertaining axial involvement in PsA patients. 

Using prospective clinic data and clinical assessments in a cohort of PsA patients, 171 patients (52% male, mean age 46.6 years) were studied. More than half (56%) reported chronic back pain.  Inflammatory back was either rheumatologist defined or defined by one of 3 accepted criteria for IBP (Calin, Rudwaleit, ASAS).

Inflammatory back pain was seen in 38% of patients and 32% had evidence of radiological changes in the spine.

The agreement between rheumatologist judgement of IBP and criteria used for IBP was highest for the Calin criteria (0.70).

Rudwaleit criteria for IBP (2.17) had the highest positive likelihood ratio for radiological axial involvement.

Amongst AxPsA with or without back pain, those with back pain had higher BASDAI scores and lower frequency of HLA-B*38 .

IBP as judged by the rheumatologist does not always agree with IBP criteria, nor will all have xrays changes of spondylitis.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Apremilast Succeeds in Scalp Psoriasis

Celgene has announced results from the phase 3 STYLE study, showing apremilast yielding significant improvement in moderate-to-severe scalp psoriasis. STYLE is a phase 3, multicenter, randomized, placebo-controlled, double-blind study evaluating the efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis of the scalp. The study enrolled 303 people who were randomized 2:1 to receive apremilast 30 mg twice daily or placebo for the first 16 weeks.

Does Gender Make a Difference in Axial Spondyloarthritis

Males and females can both be affected by axial spondyloarthritis (axSpA). A recent study shows that while there are some differences and similarities, HLA-B27 and imaging are still pivotal elements for diagnosis of axSpA in both genders.

Complementary Therapies in Psoriasis

A systematic review in Archives of Dermatology suggests that among complementary and alternative medicine (CAM) therapies, the most effective are indigo naturalis, curcumin, dietary modification, meditation, and acupuncture.

It is estimated that  nearly half of patients with psoriasis report they use CAM, although their benefits are unclear in psoriasis.

Biologic Therapies Improve Work Outcomes in Spondyloarthritis

A study from the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis (BSRBR-AS) shows that biologic use significantly improves work productivity and overall activity impairment.

 

The BSRBR-AS registry analyzed 577 participants who were employed;  28% were started on biological therapy .

BMS Tyk 2 Inhibitor Benefits Psoriasis

The NEJM reports that an oral selecive Tyrosine kinase 2 (TYK2) inhibitor of TYK2 was shown to be superior to placebo in a 12 week trial in patients with active psoriasis.